|Articles|December 1, 2002

The American Journal of Managed Care

  • December 2002
  • Volume 8
  • Issue 12

Economic Evaluation of Enoxaparin as Prophylaxis Against Venous Thromboembolism in Seriously Ill Medical Patients: A US Perspective

Download PDF: Economic Evaluation of Enoxaparin as Prophylaxis Against Venous Thromboembolism in Seriously Ill Medical Patients: A US Perspective

Articles in this issue

about 23 years ago

How Effectively Do Managed Care Organizations Influence Prescribing and Dispensing Decisions?

about 23 years ago

Characteristics of Eye Care Practices With Managed Care Contracts

about 23 years ago

Enhancing the Quality of Care for Patients With Coronary Heart Disease: The Design and Baseline Results of the Hastening the Effective Application of Research Through Technology (HEART) Trail

about 23 years ago

When Do Developing Countries Adopt Managed Care Policies and Technologies? Part II: Infrastructure, Techniques, and Reform Strategies

about 23 years ago

Profiling Resource Use: Do Different Outcomes Affect Assessments of Provider Efficiency?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text